Respiratory Disease following Viral Lung Infection Alters the Murine Gut Microbiota

• Published in: Frontiers in immunology Vol. 9; p. 182
• Main Authors: Groves, Helen T, Cuthbertson, Leah, James, Phillip, Moffatt, Miriam F, Cox, Michael J, Tregoning, John S
• Format: Journal Article
• Language: English
• Published: Switzerland Frontiers Media S.A 12.02.2018
• Subjects: Animals; Bacteria - classification; Bacteria - isolation & purification; Bacteroidetes; Bacteroidetes - isolation & purification; Female; Firmicutes; Firmicutes - isolation & purification; Gastrointestinal Microbiome; gut microbiota; Immunology; influenza; Influenza Vaccines - administration & dosage; Lipocalin-2 - analysis; Lung - virology; Mice; Mice, Inbred BALB C; Mucin 5ac; Mucin 5AC - analysis; Orthomyxoviridae; Orthomyxoviridae Infections - complications; respiratory syncytial virus infections; Respiratory Syncytial Virus Infections - complications; Respiratory Syncytial Viruses; Respiratory Tract Infections - complications; Respiratory Tract Infections - virology; RNA, Ribosomal, 16S; Vaccines, Attenuated - administration & dosage; influenza; Bacteroidetes; Mucin 5ac; respiratory syncytial virus infections; gut microbiota; Firmicutes
• DOI: 10.3389/fimmu.2018.00182
• ISSN: 1664-3224

Alterations in the composition of the gut microbiota have profound effects on human health. Consequently, there is great interest in identifying, characterizing, and understanding factors that initiate these changes. Despite their high prevalence, studies have only recently begun to investigate how viral lung infections have an impact on the gut microbiota. There is also considerable interest in whether the gut microbiota could be manipulated during vaccination to improve efficacy. In this highly controlled study, we aimed to establish the effect of viral lung infection on gut microbiota composition and the gut environment using mouse models of common respiratory pathogens respiratory syncytial virus (RSV) and influenza virus. This was then compared to the effect of live attenuated influenza virus (LAIV) vaccination. Both RSV and influenza virus infection resulted in significantly altered gut microbiota diversity, with an increase in and a concomitant decrease in phyla abundance. Although the increase in the phylum was consistent across several experiments, differences were observed at the family and operational taxonomic unit level. This suggests a change in gut conditions after viral lung infection that favors outgrowth but not individual families. No change in gut microbiota composition was observed after LAIV vaccination, suggesting that the driver of gut microbiota change is specific to live viral infection. Viral lung infections also resulted in an increase in fecal lipocalin-2, suggesting low-grade gut inflammation, and colonic Muc5ac levels. Owing to the important role that mucus plays in the gut environment, this may explain the changes in microbiota composition observed. This study demonstrates that the gut microbiota and the gut environment are altered following viral lung infections and that these changes are not observed during vaccination. Whether increased mucin levels and gut inflammation drive, or are a result of, these changes is still to be determined.